These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Role of MR imaging in the differentiation of benign and nonbenign intracranial meningiomas: the utility of contrast-enhanced T1-weighted images]. Tanaka Y, Matsuo M. Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Jan; 56(1):1-8. PubMed ID: 8857091 [Abstract] [Full Text] [Related]
9. T1 and T2 relaxation times on gadolinium-diethylenetriaminepentaacetic acid enhanced magnetic resonance images of brain tumors. Yamada S, Kubota R, Yamada K, Ono S, Hishinuma T, Matsuzawa T, Fujiwara S. Tohoku J Exp Med; 1990 Feb; 160(2):145-8. PubMed ID: 2353348 [Abstract] [Full Text] [Related]
10. [MR imaging of the meninges: normal and pathological findings]. Schörner W, Henkes H, Sander B, Felix R. Rofo; 1988 Oct; 149(4):361-8. PubMed ID: 2845502 [Abstract] [Full Text] [Related]
14. The utility of contrast media in MRI at 0.02 T. A preliminary report. Kormano M, Niemi P, Paajanen H, Määttänen H, Katevuo K. Invest Radiol; 1988 Sep; 23 Suppl 1():S289-91. PubMed ID: 3198364 [Abstract] [Full Text] [Related]
15. Magnetic resonance imaging of spinal meningiomas and neurinomas. Improvement of imaging by paramagnetic contrast enhancement. Schroth G, Thron A, Guhl L, Voigt K, Niendorf HP, Garces LR. J Neurosurg; 1987 May; 66(5):695-700. PubMed ID: 3572496 [Abstract] [Full Text] [Related]
20. Can unenhanced brain magnetic resonance imaging be used in routine follow up of meningiomas to avoid gadolinium deposition in brain? Rahatli FK, Donmez FY, Kesim C, Haberal KM, Turnaoglu H, Agildere AM. Clin Imaging; 2019 May; 53():155-161. PubMed ID: 30343167 [Abstract] [Full Text] [Related] Page: [Next] [New Search]